BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ma Q, Caillier SJ, Muzic S, Wilson MR, Henry RG, Cree BAC, Hauser SL, Didonna A, Oksenberg JR; University of California San Francisco MS-EPIC Team. Specific hypomethylation programs underpin B cell activation in early multiple sclerosis. Proc Natl Acad Sci U S A 2021;118:e2111920118. [PMID: 34911760 DOI: 10.1073/pnas.2111920118] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Boziki M, Theotokis P, Kesidou E, Karafoulidou E, Konstantinou C, Michailidou I, Bahar Y, Altintas A, Grigoriadis N. Sex, aging and immunity in multiple sclerosis and experimental autoimmune encephalomyelitis: An intriguing interaction. Front Neurol 2022;13:1104552. [PMID: 36698908 DOI: 10.3389/fneur.2022.1104552] [Reference Citation Analysis]
2 Xiao F, Rui K, Shi X, Wu H, Cai X, Lui KO, Lu Q, Ballestar E, Tian J, Zou H, Lu L. Epigenetic regulation of B cells and its role in autoimmune pathogenesis. Cell Mol Immunol 2022;19:1215-34. [PMID: 36220996 DOI: 10.1038/s41423-022-00933-7] [Reference Citation Analysis]
3 Ma Q, Oksenberg JR, Didonna A. Epigenetic control of ataxin-1 in multiple sclerosis. Ann Clin Transl Neurol 2022. [PMID: 35903875 DOI: 10.1002/acn3.51618] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Yang J, Wang J, Li H, Gao S, Fan Y, Wang K. IL-6 Promoter Hypomethylation Acts As a Diagnostic Biomarker in Hepatitis B Virus-Associated Hepatocellular Carcinoma. Front Oncol 2022;12:746643. [DOI: 10.3389/fonc.2022.746643] [Reference Citation Analysis]
5 Cree BAC, Oksenberg JR, Hauser SL. Multiple sclerosis: two decades of progress. The Lancet Neurology 2022;21:211-4. [DOI: 10.1016/s1474-4422(22)00040-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]